logo
Plus   Neg
Share
Email

Boehringer, Lilly Report Positive Top-line Phase III Empagliflozin Results

Boehringer Ingelheim and Eli Lilly and Co. (LLY) announced top-line results for four completed Phase III trials for empagliflozin, an investigational sodium glucose co-transporter-2 or SGLT-2 inhibitor being studied for type 2 diabetes or T2D treatment.

The company said that incidence of adverse events was similar for placebo, empagliflozin 10mg and 25mg, while genital infections occurred more often with empagliflozin compared with placebo. This safety information is consistent with findings reported in the Phase II trial results for empagliflozin.

Empagliflozin is being investigated in adults with T2D in a Phase III study program, which would enroll more than 14,500 patients. Totally, this program consists of eight multinational trials, including a large cardiovascular outcome trial. The pivotal studies for empagliflozin completed in 2012, and Boehringer Ingelheim and Lilly anticipate filing for regulatory review in the U.S., Europe and Japan in 2013. Boehringer Ingelheim and Lilly intend to present detailed data disclosures for many of these studies at scientific medical meetings and publications in 2013 and 2014.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Intel Corp. (INTC), the world's biggest chipmaker, Thursday said its profit and revenues for the fourth quarter trumped Wall Street estimates. The company's shares gained nearly 7 percent driven by strong outlook for the first quarter and full year 2020. Santa Clara, California-based Intel reported... ABH Pharma, Inc. and Stocknutra.com Inc. have recalled all of its dietary supplement products pursuant to a consent decree entered by the U.S. District Court for the Eastern District of New York. The companies have recalled all dietary supplement products manufactured and sold between January 2013... New York-based grocery chain Fairway Market has filed for Chapter 11 bankruptcy protection, but said its stores will remain open across the Tri-State area during the court process and it does not expect any service interruptions. This is the second time the company has filed for bankruptcy. The company earlier filed for Chapter 11 bankruptcy protection in 2016.
Follow RTT
>